INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›science›Virtual Biotech "Employs" 37,000 AI Agents for End-to-End Drug Development
science

Virtual Biotech "Employs" 37,000 AI Agents for End-to-End Drug Development

By Info60 UK Desk•Summary of reporting by Technology Networks•Sep 21, 2026•0 views•
Virtual Biotech "Employs" 37,000 AI Agents for End-to-End Drug Development
Thousands of AI agents can efficiently analyze clinical and molecular data to identify drug targets. The computational approach has enabled researchers to build a virtual lab which supports end-to-end drug development.
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

I turn up late to meetings to dodge small talk. Am I wrong? - Nature

Google News

Esther Rantzen was utterly unique... the entire nation will miss her energy

Esther Rantzen was utterly unique... the entire nation will miss her energy

Express

Simulating death can reduce people’s fear of dying

The Economist

It may soon be possible to create “mirror life”

The Economist

MI5 Issues Rare Public Alert to Stop Chinese Intelligence Benefiting From UK University Research

MI5 Issues Rare Public Alert to Stop Chinese Intelligence Benefiting From UK University Research

International Business Times

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!